In its 13F for Q4 2025 (holdings as of December 31, 2025, filed January 23, 2026), Lunate Capital Ltd reported 5 stock positions worth $263.8 million . Its top holding was Revolution Medicines (RVMD) at 66.3% of the portfolio, followed by Sailpoint (SAIL, 23.0% ) and Lineage (LINE, 8.0% ). Compared with Q3 2025, it opened 1 new position and sold out of 1. The biggest buy was a new position in Navan Class A (NAVN) and the biggest sale an exit from Figure Technology Solut Class A (FIGR).
Location AL MARYAH ISLAND, ABU DHABI, C0
CIK 0002056786
Portfolio Value $263.8M (Q4 2025) Holdings 5 stocks · $263.8M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2025 RVMD Revolution Medicines Inc. 2,196,200 $174.9M No change SAIL Sailpoint Inc. 3,000,000 $60.7M No change LINE Lineage Inc. 600,000 $21.0M No change NMRA Neumora Therapeutics Inc. 2,124,143 $3.8M No change NAVN Navan Inc. Class A 200,000 $3.4M New
Other holdings (1): bonds, preferreds, convertibles and warrants · $423K (not counted above) Security Class Shares / Principal Value Change RVMDW Revolution Medicines Inc.-28 *W EXP 12/17/202 450,000 $423K No change
Total filed on the 13F, all lines: $264.3M.
Portfolio Sells Q3 2025 → Q4 2025 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025
Stock Change vs Q3 2025 % Of Portfolio Change To Portfolio ▲ FIGR Figure Technology Solut Class A Sold out 0.00% −11.21
Portfolio Buys Q3 2025 → Q4 2025 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025
Stock Change vs Q3 2025 % Of Portfolio Change To Portfolio ▼ NAVN Navan Inc. Class A New 1.29% +1.29
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 10 $196.0M SAIL, BIRK, LINE, BXSL, GSBD Q1 2026 5 $119.6M RVMD, SAIL, LINE, NMRA, NAVN Q4 2025 5 $263.8M RVMD, SAIL, LINE, NMRA, NAVN Q3 2025 Amended 5 $220.6M RVMD, SAIL, FIGR, LINE, NMRA Q2 2025 5 $178.0M RVMD, SAIL, LINE, NMRA, IOT Q1 2025 4 $171.2M RVMD, SAIL, LINE, NMRA